$Trevi Therapeutics(TRVI.US)$Trevi Therapeutics Announces the Initiation of its Phase 2b CORAL Clinical Trial of Haduvio™ for Chronic Cough in Idiopathic Pulmonary Fibrosis (IPF) 2 MINUTES AGO, 7:30 AM EST VIA PR NEWSWIRE
Trytosaveabit楼主Massinooo:
If you don’t mind averaging down some if need be? Im sorry! I just can’t say whether to buy or sell? I only say what I’m doing! I would hate to be responsible for someone losing! Grrr! Sorry but I’m rooting for you!
$Trevi Therapeutics(TRVI.US)$Trevi Therapeutics Announces Results from Phase 2b/3 PRISM Open-Label Extension Study of Haduvio™ in Prurigo Nodularis 5 MINUTES AGO, 8:30 AM EDT VIA PR NEWSWIRE TRVI SHARE Continued reduction in WI-NRS observed among participants who remained in the study through 52 weeks of treatment Safety data over 52 weeks: treatment was well tolerated and consistent with 14-week blinded safety data Preliminary analyses presented at the European Academy of Dermatology & V...
$Trevi Therapeutics(TRVI.US)$Ayer, el ensayo de fase 2b/3 (PRISM) de Trevi Therapeutics Inc (NASDAQ:TRVI) que evaluó Haduvio (nalbufina ER) para el prurigo nodular (PN) cumplió con éxito los criterios de valoración primarios y secundarios clave. Needham escribe que Haduvio tuvo un inicio de acción rápido, alcanzando la estadística sig a las 6 semanas con una eficacia que aún no se había estancado en la lectura de la semana 14. Trevi se reunirá con la FDA antes de iniciar un ensayo de fase 3 que...
Massinooo : Is this ticker good to trade?
Trytosaveabit楼主 Massinooo: It will be eventually! Im still looking for bottom?
Massinooo : I have it for 1.16 you think I should hold?
Trytosaveabit楼主 Massinooo: If you don’t mind averaging down some if need be? Im sorry! I just can’t say whether to buy or sell? I only say what I’m doing! I would hate to be responsible for someone losing! Grrr! Sorry but I’m rooting for you!
Massinooo : Totally understand bro. I’ll keep an eye on it after market opens and will decide. Thank you bro
查看更多评论...